Stepwise approach to screen high-risk individuals using the non-laboratory-based and laboratory-based CVD risk

Noushin Fahimfar1,2, Sareh Eghtesad3, Hossein Poustchi3

  • 1Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, 1411713119, Iran.

Insights

Non-laboratory models effectively identify high-risk individuals for cardiovascular disease (CVD) in resource-limited settings. This stepwise approach reduces healthcare costs and improves efficiency by minimizing laboratory testing.

Area of Science:

  • Public Health
  • Epidemiology
  • Health Economics

Background:

  • Cardiovascular disease (CVD) poses a significant global health burden, particularly in resource-limited settings.
  • Accurate identification of high-risk populations is crucial for effective CVD prevention strategies.
  • Standard laboratory-based models for CVD risk assessment can be resource-intensive and inaccessible in many low-resource environments.

Purpose of the Study:

  • To compare the efficacy of non-laboratory CVD risk prediction models with standard laboratory-based models.
  • To evaluate the performance of World Health Organization (WHO) and Iranian pooled-cohort CVD mortality models in identifying high-risk populations.
  • To assess the potential of non-laboratory models to enhance healthcare system efficiency in resource-limited settings.

Main Methods:

  • Analysis of a national sample of 121,672 individuals aged 40-70 from the PERSIAN cohort.
  • Comparison of non-laboratory models (WHO, Iranian pooled-cohort) against a WHO laboratory-based model.
  • Statistical analysis using Intra-class Correlation Coefficient (ICC) and Concordance Correlation Coefficient (CCC).
  • Evaluation of sensitivity and specificity at various risk thresholds, with test reduction calculations based on the Iranian census.

Main Results:

  • Both non-laboratory and laboratory-based models demonstrated similar trends in predicting CVD risk across age groups.
  • Strong correlations (ICC: 94.4% men, 93.8% women) and concordance (CCC: 0.893 men, 0.883 women) were observed.
  • A stepwise approach using non-laboratory models achieved high sensitivity (99.6%) and moderate specificity (52%), significantly reducing the number of required laboratory tests by over 16 million.

Conclusions:

  • Non-laboratory CVD risk prediction models, when used in a stepwise approach, are effective in identifying high-risk populations in resource-limited settings.
  • This strategy can significantly reduce the financial burden on healthcare systems and improve overall efficiency.
  • Implementing non-laboratory models offers a promising solution for enhancing CVD screening and management in low-resource environments.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
525
Assessment of blood pressure in brachial artery(two-step method)01:23

Assessment of blood pressure in brachial artery(two-step method)

Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
660
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
185
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124